메뉴 건너뛰기




Volumn 26, Issue 11, 2015, Pages 1088-1093

Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; HEPATITIS B VACCINE; PEGINTERFERON; RIBAVIRIN; SOFOSBUVIR; ANTIVIRUS AGENT;

EID: 84942199603     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.05.004     Document Type: Note
Times cited : (23)

References (57)
  • 1
    • 34548489173 scopus 로고    scopus 로고
    • Global estimates of prevalence of HCV infection among injecting drug users
    • Aceijas C., Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy 2007, 18:352-358.
    • (2007) International Journal of Drug Policy , vol.18 , pp. 352-358
    • Aceijas, C.1    Rhodes, T.2
  • 2
    • 84905678530 scopus 로고    scopus 로고
    • Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents
    • Alavi M., Raffa J.D., Deans G.D., Lai C., Krajden M., Dore G.J., et al. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents. Liver International 2014, 34:1198-1206.
    • (2014) Liver International , vol.34 , pp. 1198-1206
    • Alavi, M.1    Raffa, J.D.2    Deans, G.D.3    Lai, C.4    Krajden, M.5    Dore, G.J.6
  • 3
    • 84880984985 scopus 로고    scopus 로고
    • Treatment of hepatitis C virus infection among people who are actively injecting drugs: A systematic review and meta-analysis
    • Aspinall E.J., Corson S., Doyle J.S., Grebely J., Hutchinson S.J., Dore G.J., et al. Treatment of hepatitis C virus infection among people who are actively injecting drugs: A systematic review and meta-analysis. Clinical Infectious Diseases 2013, 57(Suppl. 2):S80-S89.
    • (2013) Clinical Infectious Diseases , vol.57 , pp. S80-S89
    • Aspinall, E.J.1    Corson, S.2    Doyle, J.S.3    Grebely, J.4    Hutchinson, S.J.5    Dore, G.J.6
  • 4
    • 66949173719 scopus 로고    scopus 로고
    • HIV testing, human rights, and global AIDS policy: Exceptionalism and its discontents
    • Bayer R., Edington C. HIV testing, human rights, and global AIDS policy: Exceptionalism and its discontents. Journal of Health Politics, Policy and Law 2009, 34:301-323.
    • (2009) Journal of Health Politics, Policy and Law , vol.34 , pp. 301-323
    • Bayer, R.1    Edington, C.2
  • 6
    • 84881004592 scopus 로고    scopus 로고
    • Models of care for the management of hepatitis C virus among people who inject drugs: One size does not fit all
    • Bruggmann P., Litwin A.H. Models of care for the management of hepatitis C virus among people who inject drugs: One size does not fit all. Clinical Infectious Diseases 2013, 57(Suppl. 2):S56-S61.
    • (2013) Clinical Infectious Diseases , vol.57 , pp. S56-S61
    • Bruggmann, P.1    Litwin, A.H.2
  • 7
    • 82555185095 scopus 로고    scopus 로고
    • World Health Organization, Geneva
    • Chan M. Address to WHO staff 2007, World Health Organization, Geneva.
    • (2007) Address to WHO staff
    • Chan, M.1
  • 8
    • 84881019269 scopus 로고    scopus 로고
    • Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection
    • Crawford S., Bath N. Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection. Clinical Infectious Diseases 2013, 57(Suppl. 2):S75-S79.
    • (2013) Clinical Infectious Diseases , vol.57 , pp. S75-S79
    • Crawford, S.1    Bath, N.2
  • 9
    • 84871917985 scopus 로고    scopus 로고
    • Treatment of hepatitis C as prevention: A modeling case study in Vietnam
    • Durier N., Nguyen C., White L.J. Treatment of hepatitis C as prevention: A modeling case study in Vietnam. PLoS ONE 2012, 7:e34548.
    • (2012) PLoS ONE , vol.7
    • Durier, N.1    Nguyen, C.2    White, L.J.3
  • 10
    • 84865783160 scopus 로고    scopus 로고
    • Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): A pragmatic, parallel, cluster-randomised trial
    • Fairall L., Bachmann M.O., Lombard C., Timmerman V., Uebel K., Zwarenstein M., et al. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): A pragmatic, parallel, cluster-randomised trial. Lancet 2012, 380:889-898.
    • (2012) Lancet , vol.380 , pp. 889-898
    • Fairall, L.1    Bachmann, M.O.2    Lombard, C.3    Timmerman, V.4    Uebel, K.5    Zwarenstein, M.6
  • 11
    • 80053172717 scopus 로고    scopus 로고
    • The first decade of antiretroviral therapy in Africa
    • Ford N., Calmy A., Mills E.J. The first decade of antiretroviral therapy in Africa. Global Health 2011, 7:33.
    • (2011) Global Health , vol.7 , pp. 33
    • Ford, N.1    Calmy, A.2    Mills, E.J.3
  • 12
    • 84913599128 scopus 로고    scopus 로고
    • Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings
    • Ford N., Swan T., Beyer P., Hirnschall G., Easterbrook P., Wiktor S. Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings. Journal of Hepatology 2014, 61:S132-S138.
    • (2014) Journal of Hepatology , vol.61 , pp. S132-S138
    • Ford, N.1    Swan, T.2    Beyer, P.3    Hirnschall, G.4    Easterbrook, P.5    Wiktor, S.6
  • 13
    • 84880980236 scopus 로고    scopus 로고
    • Hepatitis C virus reinfection following treatment among people who use drugs
    • Grady B.P., Schinkel J., Thomas X.V., Dalgard O. Hepatitis C virus reinfection following treatment among people who use drugs. Clinical Infectious Diseases 2013, 57(Suppl. 2):S105-S110.
    • (2013) Clinical Infectious Diseases , vol.57 , pp. S105-S110
    • Grady, B.P.1    Schinkel, J.2    Thomas, X.V.3    Dalgard, O.4
  • 14
    • 84894197245 scopus 로고    scopus 로고
    • Can hepatitis C virus infection be eradicated in people who inject drugs?
    • Grebely J., Dore G.J. Can hepatitis C virus infection be eradicated in people who inject drugs?. Antiviral Research 2014, 104:62-72.
    • (2014) Antiviral Research , vol.104 , pp. 62-72
    • Grebely, J.1    Dore, G.J.2
  • 15
    • 84877051941 scopus 로고    scopus 로고
    • Hepatitis C treatment access and uptake for people who inject drugs: A review mapping the role of social factors
    • Harris M., Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: A review mapping the role of social factors. Harm Reduction Journal 2013, 10:7.
    • (2013) Harm Reduction Journal , vol.10 , pp. 7
    • Harris, M.1    Rhodes, T.2
  • 16
    • 67651083226 scopus 로고    scopus 로고
    • Hepatitis C treatment for injection drug users: A review of the available evidence
    • Hellard M., Sacks-Davis R., Gold J. Hepatitis C treatment for injection drug users: A review of the available evidence. Clinical Infectious Diseases 2009, 49:561-573.
    • (2009) Clinical Infectious Diseases , vol.49 , pp. 561-573
    • Hellard, M.1    Sacks-Davis, R.2    Gold, J.3
  • 17
    • 40749125643 scopus 로고    scopus 로고
    • Capacity enhancement of hepatitis C virus treatment through integrated, community-based care
    • Hill W.D., Butt G., Alvarez M., Krajden M. Capacity enhancement of hepatitis C virus treatment through integrated, community-based care. Canadian Journal of Gastroenterology 2008, 22:27-32.
    • (2008) Canadian Journal of Gastroenterology , vol.22 , pp. 27-32
    • Hill, W.D.1    Butt, G.2    Alvarez, M.3    Krajden, M.4
  • 18
    • 84896449505 scopus 로고    scopus 로고
    • Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries
    • Hill A., Khoo S., Fortunak J., Simmons B., Ford N. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clinical Infectious Diseases 2014, 58:928-936.
    • (2014) Clinical Infectious Diseases , vol.58 , pp. 928-936
    • Hill, A.1    Khoo, S.2    Fortunak, J.3    Simmons, B.4    Ford, N.5
  • 19
    • 84942202844 scopus 로고    scopus 로고
    • Five-year risk of late relapse or reinfection with hepatitis C after sustained virological response: Meta-analysis of 49 studies in 8534 patients
    • Abstract 654
    • Hill A., Simmons B., Saleem J., Cooke G. Five-year risk of late relapse or reinfection with hepatitis C after sustained virological response: Meta-analysis of 49 studies in 8534 patients. Conference on Retroviruses and Opportunistic Infections 2015, Abstract 654.
    • (2015) Conference on Retroviruses and Opportunistic Infections
    • Hill, A.1    Simmons, B.2    Saleem, J.3    Cooke, G.4
  • 21
    • 84907584699 scopus 로고    scopus 로고
    • "I can also serve as an inspiration": A qualitative study of the TB&Me blogging experience and its role in MDR-TB treatment
    • Horter S., Stringer B., Venis S., Du Cros P. "I can also serve as an inspiration": A qualitative study of the TB&Me blogging experience and its role in MDR-TB treatment. PLOS ONE 2014, 9:e108591.
    • (2014) PLOS ONE , vol.9
    • Horter, S.1    Stringer, B.2    Venis, S.3    Du Cros, P.4
  • 22
    • 84938138245 scopus 로고    scopus 로고
    • Strategies for the treatment of hepatitis C in an era of interferon-free therapies: What public health outcomes do we value most?
    • [Epub ahead of print]
    • Innes H., Goldberg D., Dillon J., Hutchinson S.J. Strategies for the treatment of hepatitis C in an era of interferon-free therapies: What public health outcomes do we value most?. Gut 2014, [Epub ahead of print].
    • (2014) Gut
    • Innes, H.1    Goldberg, D.2    Dillon, J.3    Hutchinson, S.J.4
  • 23
    • 84892791410 scopus 로고    scopus 로고
    • Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011
    • Iversen J., Grebely J., Topp L., Wand H., Dore G., Maher L. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011. Journal of Viral Hepatitis 2014, 21:198-207.
    • (2014) Journal of Viral Hepatitis , vol.21 , pp. 198-207
    • Iversen, J.1    Grebely, J.2    Topp, L.3    Wand, H.4    Dore, G.5    Maher, L.6
  • 24
    • 84875669416 scopus 로고    scopus 로고
    • Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting
    • Lloyd A.R., Clegg J., Lange J., Stevenson A., Post J.J., Lloyd D., et al. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting. Clinical Infectious Diseases 2013, 56:1078-1084.
    • (2013) Clinical Infectious Diseases , vol.56 , pp. 1078-1084
    • Lloyd, A.R.1    Clegg, J.2    Lange, J.3    Stevenson, A.4    Post, J.J.5    Lloyd, D.6
  • 25
    • 0037172420 scopus 로고    scopus 로고
    • HIV prevention before HAART in sub-Saharan Africa
    • Marseille E., Hofmann P.B., Kahn J.G. HIV prevention before HAART in sub-Saharan Africa. Lancet 2002, 359:1851-1856.
    • (2002) Lancet , vol.359 , pp. 1851-1856
    • Marseille, E.1    Hofmann, P.B.2    Kahn, J.G.3
  • 26
    • 79956066416 scopus 로고    scopus 로고
    • Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations?. A modeling analysis of its prevention utility
    • Martin N.K., Vickerman P., Foster G.R., Hutchinson S.J., Goldberg D.J., Hickman M. Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations?. A modeling analysis of its prevention utility. Journal of Hepatology 2011, 54:1137-1144.
    • (2011) Journal of Hepatology , vol.54 , pp. 1137-1144
    • Martin, N.K.1    Vickerman, P.2    Foster, G.R.3    Hutchinson, S.J.4    Goldberg, D.J.5    Hickman, M.6
  • 27
    • 77949540488 scopus 로고    scopus 로고
    • HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage
    • Mathers B.M., Degenhardt L., Ali H., Wiessing L., Hickman M., Mattick R.P., et al. HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet 2010, 375:1014-1028.
    • (2010) Lancet , vol.375 , pp. 1014-1028
    • Mathers, B.M.1    Degenhardt, L.2    Ali, H.3    Wiessing, L.4    Hickman, M.5    Mattick, R.P.6
  • 28
    • 55749095381 scopus 로고    scopus 로고
    • Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review
    • Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet 2008, 372:1733-1745.
    • (2008) Lancet , vol.372 , pp. 1733-1745
    • Mathers, B.M.1    Degenhardt, L.2    Phillips, B.3    Wiessing, L.4    Hickman, M.5    Strathdee, S.A.6
  • 29
    • 84908507517 scopus 로고    scopus 로고
    • Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland
    • McAllister G., Innes H., McLeod A., Dillon J.F., Hayes P.C., Fox R., et al. Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland. Journal of Clinical Virology 2014, 61:359-364.
    • (2014) Journal of Clinical Virology , vol.61 , pp. 359-364
    • McAllister, G.1    Innes, H.2    McLeod, A.3    Dillon, J.F.4    Hayes, P.C.5    Fox, R.6
  • 30
    • 84874104840 scopus 로고    scopus 로고
    • Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland
    • McDonald S.A., Hutchinson S.J., Palmateer N.E., Allen E., Cameron S.O., Goldberg D.J., et al. Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. Journal of Hepatology 2013, 58:460-466.
    • (2013) Journal of Hepatology , vol.58 , pp. 460-466
    • McDonald, S.A.1    Hutchinson, S.J.2    Palmateer, N.E.3    Allen, E.4    Cameron, S.O.5    Goldberg, D.J.6
  • 31
    • 84911123627 scopus 로고    scopus 로고
    • Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing
    • McLeod A., Weir A., Aitken C., Gunson R., Templeton K., Molyneaux P., et al. Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing. Journal of Epidemiology and Community Health 2014, 68:1182-1188.
    • (2014) Journal of Epidemiology and Community Health , vol.68 , pp. 1182-1188
    • McLeod, A.1    Weir, A.2    Aitken, C.3    Gunson, R.4    Templeton, K.5    Molyneaux, P.6
  • 33
    • 84921970817 scopus 로고    scopus 로고
    • Interventions to promote adherence to antiretroviral therapy in Africa: A network meta-analysis
    • Mills E.J., Lester R., Thorlund K., Lorenzi M., Muldoon K., Kanters S., et al. Interventions to promote adherence to antiretroviral therapy in Africa: A network meta-analysis. Lancet HIV 2014, 1:e104-e111.
    • (2014) Lancet HIV , vol.1 , pp. e104-e111
    • Mills, E.J.1    Lester, R.2    Thorlund, K.3    Lorenzi, M.4    Muldoon, K.5    Kanters, S.6
  • 34
    • 84899874212 scopus 로고    scopus 로고
    • Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model - Arizona and Utah, 2012-2014
    • Mitruka K., Thornton K., Cusick S., Orme C., Moore A., Manch R.A., et al. Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model - Arizona and Utah, 2012-2014. Morbidity and Mortality Weekly Report 2014, 63:393-398.
    • (2014) Morbidity and Mortality Weekly Report , vol.63 , pp. 393-398
    • Mitruka, K.1    Thornton, K.2    Cusick, S.3    Orme, C.4    Moore, A.5    Manch, R.A.6
  • 35
    • 84876149257 scopus 로고    scopus 로고
    • Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
    • Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57:1333-1342.
    • (2013) Hepatology , vol.57 , pp. 1333-1342
    • Mohd Hanafiah, K.1    Groeger, J.2    Flaxman, A.D.3    Wiersma, S.T.4
  • 37
    • 80051676859 scopus 로고    scopus 로고
    • Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews
    • Nelson P.K., Mathers B.M., Cowie B., Hagan H., Des Jarlais D., Horyniak D., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet 2011, 378:571-583.
    • (2011) Lancet , vol.378 , pp. 571-583
    • Nelson, P.K.1    Mathers, B.M.2    Cowie, B.3    Hagan, H.4    Des Jarlais, D.5    Horyniak, D.6
  • 38
    • 42049087886 scopus 로고    scopus 로고
    • The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users
    • Norman J., Walsh N.M., Mugavin J., Stoove M.A., Kelsall J., Austin K., et al. The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm Reduction Journal 2008, 5:8.
    • (2008) Harm Reduction Journal , vol.5 , pp. 8
    • Norman, J.1    Walsh, N.M.2    Mugavin, J.3    Stoove, M.A.4    Kelsall, J.5    Austin, K.6
  • 39
    • 84871650027 scopus 로고    scopus 로고
    • Uptake of home-based voluntary HIV testing in sub-Saharan Africa: A systematic review and meta-analysis
    • Sabapathy K., Van den Bergh R., Fidler S., Hayes R., Ford N. Uptake of home-based voluntary HIV testing in sub-Saharan Africa: A systematic review and meta-analysis. PLoS Medicine 2012, 9:e1001351.
    • (2012) PLoS Medicine , vol.9
    • Sabapathy, K.1    Van den Bergh, R.2    Fidler, S.3    Hayes, R.4    Ford, N.5
  • 40
    • 84871992334 scopus 로고    scopus 로고
    • Patients receiving opioid maintenance treatment in primary care: Successful chronic hepatitis C care in a real world setting
    • Seidenberg A., Rosemann T., Senn O. Patients receiving opioid maintenance treatment in primary care: Successful chronic hepatitis C care in a real world setting. BMC Infectious Diseases 2013, 13:9.
    • (2013) BMC Infectious Diseases , vol.13 , pp. 9
    • Seidenberg, A.1    Rosemann, T.2    Senn, O.3
  • 41
    • 0035835909 scopus 로고    scopus 로고
    • Effect of peer led programme for asthma education in adolescents: Cluster randomised controlled trial
    • Shah S., Peat J.K., Mazurski E.J., Wang H., Sindhusake D., Bruce C., et al. Effect of peer led programme for asthma education in adolescents: Cluster randomised controlled trial. BMJ 2001, 322:583-585.
    • (2001) BMJ , vol.322 , pp. 583-585
    • Shah, S.1    Peat, J.K.2    Mazurski, E.J.3    Wang, H.4    Sindhusake, D.5    Bruce, C.6
  • 42
    • 84891033806 scopus 로고    scopus 로고
    • Telephone based self-management support by 'lay health workers' and 'peer support workers' to prevent and manage vascular diseases: A systematic review and meta-analysis
    • Small N., Blickem C., Blakeman T., Panagioti M., Chew-Graham C.A., Bower P. Telephone based self-management support by 'lay health workers' and 'peer support workers' to prevent and manage vascular diseases: A systematic review and meta-analysis. BMC Health Services Research 2013, 13:533.
    • (2013) BMC Health Services Research , vol.13 , pp. 533
    • Small, N.1    Blickem, C.2    Blakeman, T.3    Panagioti, M.4    Chew-Graham, C.A.5    Bower, P.6
  • 43
    • 84917737930 scopus 로고    scopus 로고
    • Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: A cross-sectional study
    • Solomon S.S., Mehta S.H., Srikrishnan A.K., Solomon S., Mcfall A.M., Laeyendecker O., et al. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: A cross-sectional study. Lancet Infectious Diseases 2015, 15:36-45.
    • (2015) Lancet Infectious Diseases , vol.15 , pp. 36-45
    • Solomon, S.S.1    Mehta, S.H.2    Srikrishnan, A.K.3    Solomon, S.4    Mcfall, A.M.5    Laeyendecker, O.6
  • 44
    • 84901456052 scopus 로고    scopus 로고
    • Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization
    • Suthar A.B., Rutherford G.W., Horvath T., Doherty M.C., Negussie E.K. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. AIDS 2014, 28(Suppl. 2):S175-S185.
    • (2014) AIDS , vol.28 , pp. S175-S185
    • Suthar, A.B.1    Rutherford, G.W.2    Horvath, T.3    Doherty, M.C.4    Negussie, E.K.5
  • 45
    • 78650153376 scopus 로고    scopus 로고
    • Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration
    • Swan D., Long J., Carr O., Flanagan J., Irish H., Keating S., et al. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration. Aids Patient Care and STDS 2010, 24:753-762.
    • (2010) Aids Patient Care and STDS , vol.24 , pp. 753-762
    • Swan, D.1    Long, J.2    Carr, O.3    Flanagan, J.4    Irish, H.5    Keating, S.6
  • 46
    • 84890492814 scopus 로고    scopus 로고
    • Low rates of hepatitis C testing among people who inject drugs in Thailand: Implications for peer-based interventions
    • Ti L., Kaplan K., Hayashi K., Suwannawong P., Wood E., Kerr T. Low rates of hepatitis C testing among people who inject drugs in Thailand: Implications for peer-based interventions. Journal of Public Health 2013, 35:578-584.
    • (2013) Journal of Public Health , vol.35 , pp. 578-584
    • Ti, L.1    Kaplan, K.2    Hayashi, K.3    Suwannawong, P.4    Wood, E.5    Kerr, T.6
  • 47
    • 79957598042 scopus 로고    scopus 로고
    • Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs
    • Treloar C., Hull P., Bryant J., Hopwood M., Grebely J., Lavis Y. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs. Drug and Alcohol Dependence 2011, 116:52-56.
    • (2011) Drug and Alcohol Dependence , vol.116 , pp. 52-56
    • Treloar, C.1    Hull, P.2    Bryant, J.3    Hopwood, M.4    Grebely, J.5    Lavis, Y.6
  • 48
    • 0003992201 scopus 로고    scopus 로고
    • United Nations Office on Drugs and Crime, Vienna
    • UNODC World drug report 2014, United Nations Office on Drugs and Crime, Vienna.
    • (2014) World drug report
  • 49
    • 84871921104 scopus 로고    scopus 로고
    • Scaling up antiretroviral therapy in resource-limited settings: Adapting guidance to meet the challenges
    • Vitoria M., Vella S., Ford N. Scaling up antiretroviral therapy in resource-limited settings: Adapting guidance to meet the challenges. Current Opinion in HIV and AIDS 2013, 8:12-18.
    • (2013) Current Opinion in HIV and AIDS , vol.8 , pp. 12-18
    • Vitoria, M.1    Vella, S.2    Ford, N.3
  • 50
    • 84881237365 scopus 로고    scopus 로고
    • Resolution A63/15: Viral hepatitis
    • World Health Organization, Geneva, Retrieved from
    • WHO Resolution A63/15: Viral hepatitis. 63rd World Health Assembly 2010, World Health Organization, Geneva, Retrieved from http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_15-en.pdf.
    • (2010) 63rd World Health Assembly
  • 57
    • 84903795463 scopus 로고    scopus 로고
    • The treatment cascade for chronic hepatitis C virus infection in the United States: A systematic review and meta-analysis
    • Yehia B.R., Schranz A.J., Umscheid C.A., Re V.L. The treatment cascade for chronic hepatitis C virus infection in the United States: A systematic review and meta-analysis. PLOS ONE 2014, 9:e101554.
    • (2014) PLOS ONE , vol.9
    • Yehia, B.R.1    Schranz, A.J.2    Umscheid, C.A.3    Re, V.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.